PUMA BIOTECHNOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
PUMA BIOTECHNOLOGY, INC. (PBYI) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $63.13 per share as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2021-11-04
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $63.13.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $64.91.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $66.53.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $71.42.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2021-09-30 | $63.13 10-Q · filed 2021-11-04 |
| 2021-06-30 | $64.91 10-Q · filed 2021-08-05 |
| 2021-03-31 | $66.53 10-Q · filed 2021-05-06 |
| 2020-12-31 | $71.42 10-Q · filed 2021-11-04 |
| 2020-09-30 | $71.73 10-Q · filed 2020-11-05 |
| 2020-06-30 | $72.97 10-Q · filed 2020-08-06 |
| 2020-03-31 | $74.10 10-Q · filed 2020-05-07 |
| 2019-12-31 | $82.42 10-K · filed 2021-03-01 |
| 2019-09-30 | $86.08 10-Q · filed 2019-11-07 |
| 2019-06-30 | $86.90 10-Q · filed 2019-08-09 |
| 2019-03-31 | $86.34 10-Q · filed 2019-05-10 |
| 2018-12-31 | $87.49 10-K · filed 2021-03-01 |
| 2018-09-30 | $88.54 10-Q · filed 2018-11-05 |
| 2018-06-30 | $88.68 10-Q · filed 2018-08-09 |
| 2018-03-31 | $88.00 10-Q · filed 2018-05-10 |
| 2017-12-31 | $87.91 10-K · filed 2021-03-01 |
| 2017-09-30 | $87.29 10-Q · filed 2017-11-09 |
| 2017-06-30 | $86.01 10-Q · filed 2017-08-09 |
| 2017-03-31 | $84.47 10-Q · filed 2017-05-10 |
| 2016-12-31 | $87.52 10-K · filed 2020-02-28 |
| 2016-09-30 | $96.55 10-Q · filed 2016-11-09 |
| 2016-06-30 | $99.77 10-Q · filed 2016-08-09 |
| 2016-03-31 | $103.83 10-Q · filed 2016-05-10 |
| 2015-12-31 | $105.59 10-K · filed 2019-03-01 |
| 2015-09-30 | $70.12 10-Q · filed 2015-11-09 |
| 2015-06-30 | $112.75 10-Q · filed 2015-08-10 |
| 2015-03-31 | $103.65 10-Q · filed 2015-05-11 |
| 2014-12-31 | $89.55 10-K · filed 2018-03-09 |
| 2014-09-30 | $55.12 10-Q · filed 2014-11-10 |
| 2014-06-30 | $39.59 10-Q · filed 2014-08-11 |
| 2014-03-31 | $35.52 10-Q · filed 2014-05-12 |
| 2013-12-31 | $23.31 10-K · filed 2017-03-01 |
| 2013-09-30 | $14.76 10-Q · filed 2013-11-12 |
| 2013-06-30 | $11.85 10-Q · filed 2013-08-06 |
| 2013-03-31 | $10.88 10-Q · filed 2013-05-09 |
| 2012-12-31 | $8.93 10-K · filed 2016-02-29 |
| 2012-09-30 | $5.28 10-Q · filed 2012-11-14 |
| 2012-06-30 | $4.97 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |